mAbs to Bacillus anthracis capsular antigen for immunoprotection in anthrax and detection of antigenemia. - Wikidata - awgldk - TriplyDB

mAbs to Bacillus anthracis capsular antigen for immunoprotection in anthrax and detection of antigenemia.

mAbs to Bacillus anthracis capsular antigen for immunoprotection in anthrax and detection of antigenemia.

http://www.wikidata.org/entity/Q37416012

about

Human monoclonal antibodies against anthrax lethal factor and protective antigen act independently to protect against Bacillus anthracis infection and enhance endogenous immunity to anthrax Kinetics of lethal factor and poly-D-glutamic acid antigenemia during inhalation anthrax in rhesus macaques Anthrax vaccination strategies Monoclonal antibody therapies against anthrax Detection of B. anthracis spores and vegetative cells with the same monoclonal antibodies.IgG subclass and heavy chain domains contribute to binding and protection by mAbs to the poly γ-D-glutamic acid capsular antigen of Bacillus anthracis.Immunogenicity and protective efficacy of Bacillus anthracis poly-gamma-D-glutamic acid capsule covalently coupled to a protein carrier using a novel triazine-based conjugation strategy.Additional conjugation methods and immunogenicity of Bacillus anthracis poly-gamma-D-glutamic acid-protein conjugates Recombinant protective antigen 102 (rPA102): profile of a second-generation anthrax vaccine.Protective and immunochemical activities of monoclonal antibodies reactive with the Bacillus anthracis polypeptide capsule Amino acid alphabet size in protein evolution experiments: better to search a small library thoroughly or a large library sparsely?Immunogenicity of Bacillus anthracis protective antigen domains and efficacy of elicited antibody responses depend on host genetic background.Bacillus anthracis capsule activates caspase-1 and induces interleukin-1beta release from differentiated THP-1 and human monocyte-derived dendritic cells.Biosensing with nanofluidic diodes.Capsule synthesis by Bacillus anthracis is required for dissemination in murine inhalation anthrax Key role of poly-gamma-DL-glutamic acid in immune evasion and virulence of Staphylococcus epidermidis.Identification of Burkholderia cepacia complex bacteria with a lipopolysaccharide-specific monoclonal antibody.Exposure to Bacillus anthracis capsule results in suppression of human monocyte-derived dendritic cells Polysaccharide specific monoclonal antibodies provide passive protection against intranasal challenge with Burkholderia pseudomallei.Panning of a phage display library against a synthetic capsule for peptide ligands that bind to the native capsule of Bacillus anthracis Cathelicidin administration protects mice from Bacillus anthracis spore challenge Pre- and postexposure protection against virulent anthrax infection in mice by humanized monoclonal antibodies to Bacillus anthracis capsule Immunomodulation with CD40 stimulation and interleukin-2 protects mice from disseminated cryptococcosis Detection of anthrax toxin in the serum of animals infected with Bacillus anthracis by using engineered immunoassays Identification of circulating bacterial antigens by in vivo microbial antigen discovery.The poly-γ-D-glutamic acid capsule of Bacillus anthracis enhances lethal toxin activity.Toxin-deficient mutants of Bacillus anthracis are lethal in a murine model for pulmonary anthrax Immunoassay for Capsular Antigen of Bacillus anthracis Enables Rapid Diagnosis in a Rabbit Model of Inhalational Anthrax.Antibodies against anthrax: mechanisms of action and clinical applications.Poly-gamma-glutamate capsule-degrading enzyme treatment enhances phagocytosis and killing of encapsulated Bacillus anthracis Bacillus anthracis Capsular Conjugates Elicit Chimpanzee Polyclonal Antibodies That Protect Mice from Pulmonary Anthrax.Analysis of epitope information related to Bacillus anthracis and Clostridium botulinum.The Poly-γ-d-Glutamic Acid Capsule Surrogate of the Bacillus anthracis Capsule Is a Novel Toll-Like Receptor 2 Agonist.The evolving field of biodefence: therapeutic developments and diagnostics.Monoclonal antibodies and toxins--a perspective on function and isotype.Expression of either lethal toxin or edema toxin by Bacillus anthracis is sufficient for virulence in a rabbit model of inhalational anthrax In vivo Distribution and Clearance of Purified Capsular Polysaccharide from Burkholderia pseudomallei in a Murine Model.Treatment of experimental anthrax with recombinant capsule depolymerase In vivo fate and distribution of poly-gamma-D-glutamic acid, the capsular antigen from Bacillus anthracis.Past, imminent and future human medical countermeasures for anthrax.

P2860

Q24682011-7C1747DA-FE85-40CD-9E71-A2737E60D686 Q28389893-ADD96730-3709-4DC0-9129-3D04E8CACD43 Q28392248-C4DD8470-64A4-4BCF-BA9B-F3E53F79BC1D Q28393072-157528C9-8DEB-4C7D-85BD-1A724994E97D Q30885995-859D411E-6F8D-4C64-A911-60C58AFD8B53 Q31116360-DA50F35C-4C3B-436A-885D-84B9D035A0A9 Q33227409-82306581-A4A8-4375-9861-813A91EC204F Q33251442-BECA4ECC-6738-469D-8812-2313326CC60F Q33258307-52AF5B4B-C60E-4942-AE78-EF564950E017 Q33261310-F0167807-EA5F-43B8-9E2E-9C43283302D8 Q33326227-9CE65F8D-A550-4679-BC36-E2399FDC3D78 Q33334776-8D3A3235-5A24-4FDB-8713-41825AEC51BA Q33557788-EF4E3CC9-37D2-4C81-8AF1-8D6CA522437B Q33641004-D0A7B72B-0C0F-4A4A-A717-C80486FE1AB0 Q33739694-C9B4FCF8-261D-412F-9B70-DCD10145E8C9 Q33778606-8E9C96EB-3F49-4A75-AF7D-7E11474386B9 Q33920487-846BFF8C-10EE-475E-8155-3C75E98435C5 Q34059054-AB1EF3C5-161F-475E-B7BF-6AF0237B43AF Q34243707-B2BADC04-940F-4DCB-B0F0-E088176305B0 Q34429143-A6140748-0765-4006-9D17-644726BD77AD Q34476038-FBFD159E-D7EB-4E64-916E-961AA4EFB5BA Q34490786-84A34B18-5410-4A74-B470-E0A19EAD18BD Q34492622-C1C4A6CF-BA9D-41B3-BD09-7AF1CE0F5AE4 Q34720183-E844455F-81EC-4192-A28B-64F80E489AAE Q35187007-46C21CF3-4C03-4C13-83A9-F800E80934EF Q35191941-436BC1A2-D354-4D17-82CF-6EE2CC02ED7D Q35217494-FBAD9B8B-1D99-4024-962B-E3DEC1CA88D9 Q35571163-E723C25C-09C6-478F-9AFD-3898EB078A32 Q35610439-6B728796-37B4-40CF-A489-B83008CE6041 Q35635634-25E22409-9DE1-4485-B3FA-03B3611C896A Q35652068-307A8F8B-20BA-4383-A64A-48E173AF0153 Q35869311-12CA1BC6-B474-41BC-B52E-2A65D0E519D4 Q36053487-6835D612-2C66-41D6-A7CF-B68F4254B660 Q36085668-296DAF89-F3D9-40E6-A05E-AFE736F27542 Q36099489-DBA0855A-30E5-410F-9A74-BA2B5E708173 Q36155940-48E8E379-1DF4-4419-ACD0-FC00EE7C16A7 Q36219974-4F2DFB87-0CEC-4D15-8479-6FB272F65DC2 Q36482838-A368F84D-E6A0-40C0-92E1-CE7D60C2674A Q36483647-947203F0-27C3-48E3-9F25-D058ACD58A26 Q36565152-0E4D3777-B801-49ED-9723-262AB91A5C6A

P2860

mAbs to Bacillus anthracis capsular antigen for immunoprotection in anthrax and detection of antigenemia.

http://www.wikidata.org/entity/Q37416012

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 29 March 2004

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

mAbs to Bacillus anthracis cap ...... and detection of antigenemia.

@en

mAbs to Bacillus anthracis cap ...... and detection of antigenemia.

@nl

type

label

mAbs to Bacillus anthracis cap ...... and detection of antigenemia.

@en

mAbs to Bacillus anthracis cap ...... and detection of antigenemia.

@nl

prefLabel

mAbs to Bacillus anthracis cap ...... and detection of antigenemia.

@en

mAbs to Bacillus anthracis cap ...... and detection of antigenemia.

@nl

P1433

Q37416012-200D9C81-BB53-4AAA-A24A-C2A217BDD646

P1476

Q37416012-9300ADFC-9457-4779-8F67-72E28CDCA019

P2093

Q37416012-090D9BC7-6749-412D-A1A5-F52F03B584F0

Q37416012-418C0000-7F69-4DC4-AE39-55BA8F1907C0

Q37416012-47A3EA2B-95A7-4E2F-9A66-B6A0FE85F865

Q37416012-8D97C40A-3D24-4D98-B179-C09706349645

Q37416012-9FF94D15-C500-4E34-864B-03C40E0A8A30

Q37416012-AA782FAF-6ECB-4F06-B52B-7BDAD440C5A0

P2860

Q37416012-0E45C29F-8711-4AD9-BD9F-69B72F5E410C

Q37416012-188FF3D1-C76D-40F9-AC49-BE9A0682FED9

Q37416012-29D61740-5AF9-46BB-BF24-45F59BED4D93

Q37416012-3197CDD2-6AD4-4317-9888-84DC4CE90CC4

Q37416012-373A3BD3-79A4-43AA-BFA4-706068D211AB

Q37416012-455AAEB5-CF1E-4989-ABFF-D3CE189992E2

Q37416012-571FFF46-B4AB-42BA-AF08-0F200A816458

Q37416012-575260F3-B531-4C8D-8B73-BD66E81B38CD

Q37416012-59F6A181-0B39-4CE0-AB7B-F793331AAC4E

Q37416012-744905DA-4F05-4FA0-9BB4-2C014B2BA9CF

P304

Q37416012-2B557843-92D0-46B9-8859-EA72A68F0126

P31

Q37416012-1A28A35E-B225-4993-89E2-B96AE780376E

P356

Q37416012-8D47D6B8-39E7-44DB-9EAA-29E33F1AD659

P407

Q37416012-E2742E2A-4C5B-4EBE-AFDB-0F2CC44CF516

P433

Q37416012-E51F8B04-7875-4734-857E-4944F6022CF4

P478

Q37416012-50596263-D6B3-4236-A026-A55BE46CC3AB

P50

Q37416012-8F30F44E-AFE2-4F9F-B14C-5A548F99690C

Q37416012-fd4217bf-4816-04e6-a9f0-1f8fcf2b7cfe

P577

Q37416012-9F501A22-EFE4-44EC-8544-4A89E0314F21

P5875

Q37416012-190DC503-1D8C-4935-856B-697CE25B2C7E

P698

Q37416012-AA8A21FD-581B-4B14-803B-8972943BF4D0

P932

Q37416012-2D36EC45-BE2B-48CA-BB86-456063CB7025

P356

PNAS.0401351101

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

mAbs to Bacillus anthracis cap ...... and detection of antigenemia.

@en

P2093

Ann Percival

http://www.w3.org/2001/XMLSchema#string

C Rick Lyons

http://www.w3.org/2001/XMLSchema#string

Julie A Lovchik

http://www.w3.org/2001/XMLSchema#string

Peter Thorkildson

http://www.w3.org/2001/XMLSchema#string

Suzanne Brandt

http://www.w3.org/2001/XMLSchema#string

William J Murphy

http://www.w3.org/2001/XMLSchema#string

P2860

Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States

Colorimetric Method for Determination of Sugars and Related Substances

In vitro method for testing the toxin-producing capacity of diphtheria bacteria

Anthrax as a biological weapon, 2002: updated recommendations for management

Germination of Bacillus anthracis spores within alveolar macrophages.

Poly(gamma-D-glutamic acid) protein conjugates induce IgG antibodies in mice to the capsule of Bacillus anthracis: a potential addition to the anthrax vaccine.

Monoclonal antibodies reactive with immunorecessive epitopes of glucuronoxylomannan, the major capsular polysaccharide of Cryptococcus neoformans

A dually active anthrax vaccine that confers protection against both bacilli and toxins.

Regulation of the Bacillus anthracis protective antigen gene: CO2 and a trans-acting element activate transcription from one of two promoters.

P304

5042-5047

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0401351101

http://www.w3.org/2001/XMLSchema#string

P407

P433

14

http://www.w3.org/2001/XMLSchema#string

P478

101

http://www.w3.org/2001/XMLSchema#string

P50

Thomas R. Kozel

P577

2004-03-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8649076

http://www.w3.org/2001/XMLSchema#string

P698

15051894

http://www.w3.org/2001/XMLSchema#string

P932

387370

http://www.w3.org/2001/XMLSchema#string